NIH-funded research R03 grant

Modeling ALS Pathology with Patient-Derived Neuromuscular Organoids

Official title: Modeling ALS Pathogenesis Using Human iPSC-Derived Neuromuscular Organoids

Funded at Louisiana State Univ Hsc Shreveport · NIH-11429409 · Data updated 2026-11-12

A study using patient-derived stem cells to grow 3D neuromuscular organoids that mimic ALS-affected connections between nerves and muscles.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionLouisiana State Univ Hsc Shreveport
NIH-funded
Lab location1 site (Shreveport, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$146,000
NIH project number1R03NS151051-01
Project IDNIH-11429409 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with juvenile or early-onset ALS and healthy donors whose iPSCs can be reprogrammed; organoids will be derived from these cells.

Less likely to help

Healthy individuals without ALS may not directly benefit from the findings.

What this research studies

Researchers will create three-dimensional neuromuscular organoids from human iPSCs, including spinal motor neurons, muscle fibers, and glia, to model ALS in a dish. The project will compare organoids from individuals with juvenile/early-onset ALS to healthy controls and isogenic corrected lines to understand how ALS alters neuromuscular development and connectivity. They will test structural and functional features of the neuromuscular junctions and assess disease-related changes over time to identify potential mechanisms and targets. This work aims to establish a robust, physiologically relevant model that can be used to study disease progression and screen potential therapies.

Why it matters

Potential benefit: If successful, patients could benefit from a better understanding of ALS mechanisms and accelerated development of targeted treatments.

How similar studies have gone: 3D neuromuscular organoids have shown promise, but applying them to ALS pathology is an active, yet progressing area with emerging positive signals.

Where this research is happening

  • Louisiana State Univ Hsc Shreveport
    Shreveport, United States
    Active

Researchers

  • Principal investigator: Ding, Baojin — Louisiana State Univ Hsc Shreveport
  • Study coordinator: Ding, Baojin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.